Evidence map›Paper›PMID 39401286›Full record

ArticleMedical physics2025

Using a patient-specific diffusion model to generate CBCT-based synthetic CTs for CBCT-guided adaptive radiotherapy.

Xiaoqian Chen, Richard L J Qiu, Tonghe Wang, Chih-Wei Chang, Xuxin Chen, Joseph W Shelton, Aparna H Kesarwala, Xiaofeng Yang

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Deep Learning for CT Synthesis in Radiotherapy.Bioengineering (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoqian ChenDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Richard L J QiuDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Tonghe WangDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Chih-Wei ChangDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Xuxin ChenDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Joseph W SheltonDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Aparna H KesarwalaDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Xiaofeng YangDepartment of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Translational and Clinical Trial Correlates CoreU54CA274513 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Claudia Marcela Diaz-Montero · 2022 to 2026
$9.3M
eXtended Modular ANthropomorphic (XMAN) phantom for Imaging and Treatment Optimization in Radiotherapy.R01EB032680 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI REN, LEI, YANG, XIAOFENG · 2022 to 2025
$2.4M
Real-time Volumetric Imaging for Motion Management and Dose Delivery VerificationR01CA272991 · NCI · EMORY UNIVERSITY · PI Zhen Tian, Xiaofeng Yang · 2023 to 2026
$2.3M
Intelligent and Personalized Online Adaptive Proton TherapyR01DE033512 · NIDCR · UNIVERSITY OF CHICAGO · PI Zhen Tian, Xiaofeng Yang · 2024 to 2026
$1.8M
Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung CancerR21EB033994 · NIBIB · EMORY UNIVERSITY · PI KESARWALA, APARNA · 2023 to 2025
$822k
Memorial Sloan Kettering Cancer Center Support Grant/Core Grant P30CA008748NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA272991NCI NIH HHS U54 CA274513NIBIB NIH HHS R01 EB032680NIBIB NIH HHS R21 EB033994NIDCR NIH HHS R01 DE033512NIH HHS R01CA272991NIH HHS R01DE033512NIH HHS R21EB033994NIH HHS U54CA274513
6 · The paper itself

Abstract

backgroundCone beam computed tomography (CBCT) can be used to evaluate the inter-fraction anatomical changes during the entire course for image-guided radiotherapy (IGRT). However, CBCT artifacts from various sources restrict the full application of CBCT-guided adaptive radiation therapy (ART). PURPOSE: Inter-fraction anatomical changes during ART, including variations in tumor size and normal tissue anatomy, can affect radiation therapy (RT) efficacy. Acquiring high-quality CBCT images that accurately capture patient- and fraction-specific (PFS) anatomical changes is crucial for successful IGRT.

methodsTo enhance CBCT image quality, we proposed PFS lung diffusion models (PFS-LDMs). The proposed PFS models use a pre-trained general lung diffusion model (GLDM) as a baseline, which is trained on historical deformed CBCT (dCBCT)-planning CT (pCT) paired data. For a given patient, a new PFS model is fine-tuned on a CBCT-deformed pCT (dpCT) pair after each fraction to learn the PFS knowledge for generating personalized synthetic CT (sCT) with quality comparable to pCT or dpCT. The learned PFS knowledge is the specific mapping relationships, including personal inter-fraction anatomical changes between personalized CBCT-dpCT pairs. The PFS-LDMs were evaluated on an institutional lung cancer dataset, quantified by mean absolute error (MAE), peak signal-to-noise ratio (PSNR), normalized cross-correlation (NCC), and structural similarity index measure (SSIM) metrics. We also compared our PFS-LDMs with a mainstream GAN-based model, demonstrating that our PFS fine-tuning strategy could be applied to existing generative models.

resultsOur models showed remarkable improvements across all four evaluation metrics. The proposed PFS-LDMs outperformed the GLDM, demonstrating the effectiveness of our proposed fine-tuning strategy. The PFS model fine-tuned with CBCT images from four prior fractions, reduced the MAE from 103.95 to 15.96 Hounsfield units (HU), and increased the mean PSNR, NCC, and SSIM from 25.36 dB to 33.57 dB, 0.77 to 0.98, and 0.75 to 0.97, respectively. Applying our PFS fine-tuning strategy to a Cycle GAN model also showed improvements, with all four fine-tuned PFS Cycle GAN (PFS-CG) models outperforming the general Cycle GAN model. Overall, our proposed PFS fine-tuning strategy improved CBCT image quality compared to both the pre-correction and non-fine-tuned general models, with our proposed PFS-LDMs yielding better performance than the GAN-based model across all metrics.

conclusionsOur proposed PFS-LDMs significantly improve CBCT image quality with increased HU accuracy and fewer artifacts, thus better capturing inter-fraction anatomical changes. This lays the groundwork for enabling CBCT-based ART, which could enhance clinical efficiency and achieve personalized high-precision treatment by accounting for inter-fraction anatomical changes.

Indexed as

Cone-Beam Computed TomographyRadiotherapy, Image-GuidedDiffusionHumansImage Processing, Computer-AssistedLung NeoplasmsPatient-Specific ModelingRadiotherapy Planning, Computer-Assisteddiffusion modelfraction‐specificimage‐guided radiation therapy (IGRT)lung CBCTpatient‐specificsynthesized CT

Identifiers

PMID39401286
PMCPMC11700746

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.